Article
Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study.
Scientific reports - 11 Mar 2021
Jiang Fuman, Liu Weiqiang, Zhang Longmei, Guo Yulai, Chen Min, Zeng Xiaojing, Wang Yang, Li Yufan, Xian JiaJia, Du BoLe, Xie Yuhuan, Ouyang Shuming, Li Sheng, Yang Yinghong, Zhang Chunsheng, Luo Fei, Sun Xiaofang
Abstract excerpt
Noninvasive prenatal testing (NIPT) for single gene disorders remains challenging. One approach that allows for accurate detection of the slight increase of the maternally inherited allele is the relative haplotype dosage (RHDO) analysis, which requires the construction of parental haplotypes. Recently, the nanopore sequencing technologies have become available and may be an ideal tool for direct construction of...
Topics
Join the communities discussing this publication.
